B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Viomycin

300 PubMed studies analyzed ยท Evidence Score: 41.7

Research Domains

Viomycin has been studied across 9 research domains including ๐Ÿซ Respiratory, ๐Ÿซ˜ Kidney, ๐Ÿง  Focus & Attention, ๐Ÿ”ฅ Metabolic, ๐Ÿ‹๏ธ Muscle & Hypertrophy. The primary research focus is ๐Ÿซ Respiratory with 19% of studies addressing this area.

Loading evidence profile...

This evidence profile for Viomycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.